Differential inhibitory effect of L‐lysine on renal accumulation of 67Cu‐labelled F(ab′)2 fragments in mice
暂无分享,去创建一个
R. A. Rutherford | P. Schubiger | R. Rutherford | R. Waibel | A. Smith | Alan Smith | P. August Schubiger
[1] H. Amstutz,et al. Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] M. Welch,et al. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. , 1996, Bioconjugate chemistry.
[3] Wendy S. Becker,et al. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] I. Bernstein,et al. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. , 1996, Cancer research.
[5] P. Schubiger,et al. Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate. , 1996, Bioconjugate chemistry.
[6] G. Snow,et al. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] N. Kotite,et al. Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate. , 1995, Cancer research.
[8] Wendy S. Becker,et al. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. , 1995, Cancer research.
[9] P. Cutler,et al. Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] R. Owens,et al. Improved tumor targeting with chemically cross-linked recombinant antibody fragments. , 1994, Cancer research.
[11] P. Schubiger,et al. Preclinical evaluation of 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb35. , 1993, Cancer research.
[12] Jerry R. Williams,et al. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] J. Baak,et al. Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients. , 1993, Cancer research.
[14] V. Torchilin,et al. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. , 1993, Nuclear medicine and biology.
[15] F. Lang,et al. Hepatic regulation of renal function , 1992, Experimental physiology.
[16] M. Nedelman,et al. Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugate. , 1990, Bioconjugate chemistry.
[17] L. Racusen,et al. Effects of lysine and other amino acids on kidney structure and function in the rat. , 1985, The American journal of pathology.
[18] C. Mogensen,et al. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. , 1977, Scandinavian journal of clinical and laboratory investigation.
[19] H. Amstutz,et al. Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells. , 1995, Cancer research.
[20] G. Borm,et al. Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator. , 1994, Nuclear medicine and biology.
[21] R. Stahel,et al. A comparison of 67Cu‐ and 131I‐labelled forms of monoclonal antibodies SEN7 and SWA20 directed against small‐cell lung cancer , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[22] T Takahashi,et al. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. , 1993, Cancer research.
[23] P. Bunn,et al. Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling. , 1986, Methods in enzymology.
[24] M. Trucco,et al. 1 – Determination of Equilibrium Binding Parameters of Monoclonal Antibodies Specific for Cell Surface Antigens , 1981 .